Ethyl Eicosapentanoic Acid (Ethyl-EPA) for Treating Major Depression

This study has been completed.

Study NCT00096798 Information provided by National Center for Complementary and Alternative Medicine (NCCAM)

First Received: November 15, 2004 Last Updated: January 15, 2008 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study has been completed.
Study Completion Date:	August 2007
Primary Completion Date:	August 2007 (Final data collection date for primary outcome measure)

No publications provided by National Center for Complementary and Alternative Medicine (NCCAM)

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Mischoulon D, Papakostas GI, Dording CM, Farabaugh AH, Sonawalla SB, Agoston AM, Smith J, Beaumont EC, Dahan LE, Alpert JE, Nierenberg AA, Fava M. A double-blind, randomized controlled trial of ethyl-eicosapentaenoate for major depressive disorder. J Clin Psychiatry. 2009 Dec;70(12):1636-44. Epub 2009 Aug 25.